These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7262472)

  • 21. Response of extrapancreatic glucagon to arginine in dogs.
    Ohneda A; Kobayashi T; Nihei J; Umezu M; Sakai T; Sanoyama K
    Tohoku J Exp Med; 1979 Sep; 129(1):45-54. PubMed ID: 494257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of glucagon deficiency in the Houssay phenomenon of dogs.
    Nakabayashi H; Dobbs RE; Unger RH
    J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential immunoreactivity of plasma glucagon components in man: studies with different glucagon antibodies.
    Soybel D; Jaspan J; Polonsky K; Goldberg I; Rayfield E; Tager H
    J Clin Endocrinol Metab; 1983 Mar; 56(3):612-8. PubMed ID: 6185527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
    Hendriks T; Jansen JB; van Tongeren JH
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):226-32. PubMed ID: 6141691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained feeding or fasting affects levels of glucagon (IRG) in porcine plasma, gut and pancreas.
    Fourie AJ; Millar R; Child P; Hickman R
    Scand J Gastroenterol Suppl; 1987; 138():1-19. PubMed ID: 3479835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excessive circulating large molecular weight immunoreactive glucagon components in subjects with the idiopathic postprandial syndrome.
    Charles MA; Waldeck N
    J Clin Endocrinol Metab; 1981 Aug; 53(2):366-71. PubMed ID: 6265488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on glucagon secretion in obese rats with hypothalamic lesions (author's transl)].
    Suehiro F; Chikamori K
    Nihon Naibunpi Gakkai Zasshi; 1980; 56(12):1606-17. PubMed ID: 7009230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon immunoreactivity and chromatographic profiles in pancreatectomized humans. Paradoxical response to oral glucose.
    Bajorunas DR; Fortner JG; Jaspan JB
    Diabetes; 1986 Aug; 35(8):886-93. PubMed ID: 3525286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastric A-cell function in insulin-deprived depancreatized dogs.
    Blazquez E; Muñoz-Barragan L; Patton GS; Orci L; Dobbs RE; Unger RH
    Endocrinology; 1976 Nov; 99(5):1182-8. PubMed ID: 991814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of glucagon secretion by gastric inhibitory polypeptide in patients with hepatic cirrhosis and hyperglucagonemia.
    Dupre J; Caussignac Y; McDonald TJ; Van Vliet S
    J Clin Endocrinol Metab; 1991 Jan; 72(1):125-9. PubMed ID: 1986010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma glucagon in pups, decreased by fasting, unaffected by somatostatin or hypoglycemia.
    Hetenyi G; Kovacevic N; Hall SE; Vranic M
    Am J Physiol; 1976 Nov; 231(5 Pt. 1):1377-82. PubMed ID: 998780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes.
    Kuku SF; Zeidler A; Emmanouel DS; Katz AI; Rubenstein AH
    J Clin Endocrinol Metab; 1976 Jan; 42(1):173-6. PubMed ID: 1249185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degradation of [125I]iodoglucagon by normal rat plasma in radioimmunoassay mixture containing aprotinin and its prevention by p-chloromercuriphenyl sulfonate and leupeptin.
    Tsubouchi H; Miyazaki H; Gohda E; Nakayama H; Nakazono Y; Daikuhara Y; Hashimoto S
    Endocrinology; 1986 Sep; 119(3):1137-45. PubMed ID: 2426096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon release induced by pancreatic nerve stimulation in the dog.
    Marliss EB; Girardier L; Seydoux J; Wollheim CB; Kanazawa Y; Orci L; Renold AE; Porte D
    J Clin Invest; 1973 May; 52(5):1246-59. PubMed ID: 4349486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of stimulation of endogenous glucagon secretion by amino acid administration on canine hepatic bile flow.
    Kaminski DL; Deshpande Y; Beinfeld MC
    Dig Dis Sci; 1987 Apr; 32(4):401-8. PubMed ID: 3829881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoreactive glucagon in the vascular walls of the rat.
    Tanaka J; Shiosaka S; Tsubouchi H; Gohda E; Daikuhara Y; Tohyama M
    Life Sci; 1983 Oct; 33(16):1599-604. PubMed ID: 6355735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of experimental hyperammonemia on the secretion of insulin and glucagon in the rat].
    Schlienger JL; Sapin R; Imler M
    C R Seances Soc Biol Fil; 1980; 174(2):199-204. PubMed ID: 6446964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of insulin and glucagon in the plasma aminoacid imbalance of chronic hepatic encephalopathy.
    Marchesini G; Zoli M; Forlani G
    Z Gastroenterol; 1979 Jul; 17(7):469-76. PubMed ID: 382661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased "large glucagon-immunoreactivity".
    Recant L; Perrino PV; Bhathena SJ; Danforth DN; Lavine RL
    Diabetologia; 1976 Aug; 12(4):319-26. PubMed ID: 183997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.